List of Psioxus Therapeutics Limited patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11000559 Oncolytic adenovirus encoding a B7 protein	Patent 11000559 was granted and assigned to Psioxus Therapeutics Limited on May, 2021 by the United States Patent and Trademark Office.	‌ Psioxus Therapeutics Limited	‌ Psioxus Therapeutics Limited	United States Patent and Trademark Office	11000559	May 11, 2021
‌ US Patent 11155622 Virus encoding an anti-TCR-complex antibody or fragment	Patent 11155622 was granted and assigned to Psioxus Therapeutics Limited on October, 2021 by the United States Patent and Trademark Office.	‌ Psioxus Therapeutics Limited	‌ Psioxus Therapeutics Limited	United States Patent and Trademark Office	11155622	October 26, 2021
‌ US Patent 11439678 Oncolytic adenoviruses armed with heterologous genes		‌ Psioxus Therapeutics Limited	‌ Psioxus Therapeutics Limited	United States Patent and Trademark Office	11439678	September 13, 2022
‌ US Patent 11173186 Dosing regime and formulations for type B adenovirus	Patent 11173186 was granted and assigned to Psioxus Therapeutics Limited on November, 2021 by the United States Patent and Trademark Office.	‌ Psioxus Therapeutics Limited	‌ Psioxus Therapeutics Limited	United States Patent and Trademark Office	11173186	November 16, 2021
‌ US Patent 11142580 Oncolytic virus and method	Patent 11142580 was granted and assigned to Psioxus Therapeutics Limited on October, 2021 by the United States Patent and Trademark Office.		‌ Psioxus Therapeutics Limited	United States Patent and Trademark Office	11142580	October 12, 2021
‌ US Patent 10849945 Oncolytic adenovirus encoding a B7 protein or active fragment	Patent 10849945 was granted and assigned to Psioxus Therapeutics Limited on December, 2020 by the United States Patent and Trademark Office.		‌ Psioxus Therapeutics Limited	United States Patent and Trademark Office	10849945	December 1, 2020
‌ US Patent 10322152 Oncolytic adenovirus encoding a B7 protein	Patent 10322152 was granted and assigned to Psioxus Therapeutics Limited on June, 2019 by the United States Patent and Trademark Office.	‌ Psioxus Therapeutics Limited	‌ Psioxus Therapeutics Limited	United States Patent and Trademark Office	10322152	June 18, 2019
‌ US Patent 10472648 Method of making adenovirus and corresponding plasmids	Patent 10472648 was granted and assigned to Psioxus Therapeutics Limited on November, 2019 by the United States Patent and Trademark Office.		‌ Psioxus Therapeutics Limited	United States Patent and Trademark Office	10472648	November 12, 2019